BOPW
AZN icon

Brandywine Oak Private Wealth’s AstraZeneca AZN Stock Holding History

Brandywine Oak Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33M Sell
28,116
-696
-2% -$131K 0.4% 31
2026
Q1 		$5.68M Sell
28,812
-1,773
-6% -$342K 0.48% 30
2025
Q4 		$5.62M Sell
30,585
-1,787
-6% -$313K 0.47% 31
2025
Q3 		$4.97M Sell
32,372
-863
-3% -$131K 0.43% 31
2025
Q2 		$4.64M Buy
33,235
+473
+1% +$66.3K 0.43% 33
2025
Q1 		$4.82M Sell
32,762
-1,063
-3% -$154K 0.47% 32
2024
Q4 		$4.43M Buy
33,825
+22
+0.1% +$3.08K 0.43% 35
2024
Q3 		$5.27M Sell
33,803
-6,412
-16% -$1.04M 0.51% 32
2024
Q2 		$6.27M Sell
40,215
-1,966
-5% -$296K 0.64% 24
2024
Q1 		$5.72M Sell
42,181
-8
-0% -$1.06K 0.6% 25
2023
Q4 		$5.68M Sell
42,189
-191
-0.5% -$24.8K 0.63% 23
2023
Q3 		$5.74M Sell
42,380
-1,583
-4% -$216K 0.67% 24
2023
Q2 		$6.29M Sell
43,963
-816
-2% -$120K 0.7% 23
2023
Q1 		$6.22M Buy
44,779
+28,810
+180% +$3.88M 0.73% 23
2022
Q4 		$2.17M Sell
15,969
-1,820
-10% -$228K 0.27% 57
2022
Q3 		$1.95M Sell
17,789
-632
-3% -$80.2K 0.26% 61
2022
Q2 		$2.43M Sell
18,421
-3
-0% -$394 0.31% 48
2022
Q1 		$2.44M Sell
18,424
-2,089
-10% -$251K 0.28% 66
2021
Q4 		$2.39M Buy
20,513
+865
+4% +$102K 0.26% 66
2021
Q3 		$2.35M Sell
19,648
-221
-1% -$25.7K 0.27% 63
2021
Q2 		$2.38M Buy
19,869
+1,081
+6% +$119K 0.28% 60
2021
Q1 		$1.87M Buy
18,788
+113
+0.6% +$11.4K 0.28% 59
2020
Q4 		$1.87M Buy
18,675
+120
+0.6% +$12.7K 0.28% 58
2020
Q3 		$2.03M Sell
18,555
-1,586
-8% -$176K 0.34% 48
2020
Q2 		$2.13M Buy
20,141
+796
+4% +$82.2K 0.38% 46
2020
Q1 		$1.73M Buy
19,345
+1,713
+10% +$161K 0.36% 47
2019
Q4 		$1.76M Sell
17,632
-821
-4% -$77.3K 0.32% 50
2019
Q3 		$1.64M Sell
18,453
-804
-4% -$69.7K 0.31% 53
2019
Q2 		$1.59M Sell
19,257
-2,099
-10% -$165K 0.32% 52
2019
Q1 		$1.73M Sell
21,356
-991
-4% -$78.1K 0.36% 45
2018
Q4 		$1.7M Buy
+22,347
New +$1.75M 0.38% 44

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Brandywine Oak Private Wealth's AZN Position: Q2 2026 in Review

Brandywine Oak Private Wealth reduced its AstraZeneca (AZN) stake by 2.4% in Q2 2026, selling an estimated $131K and leaving 28,116 shares worth $5.33M. The position accounts for 0.4% of the portfolio, ranked #31.

Brandywine Oak Private Wealth first reported a position in AZN in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.29M in Q2 2023. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Brandywine Oak Private Wealth held 28,116 shares of AstraZeneca worth $5.33M as of Q2 2026.
  • Brandywine Oak Private Wealth sold 696 AstraZeneca shares in Q2 2026, an estimated $131K.
  • AstraZeneca made up 0.4% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #31 holding.
  • Brandywine Oak Private Wealth first reported a position in AstraZeneca in Q4 2018 and has held it in 31 quarters since.
  • Brandywine Oak Private Wealth's AstraZeneca position peaked at $6.29M in Q2 2023.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.